The journal of nutrition, health & aging

, Volume 23, Issue 4, pp 378–380 | Cite as

Overwhelming Underuse of Bisphosphonates in French Nursing Home Residents After Proximal Femoral Fracture

  • Paul Le FlochEmail author
  • P. Kermarrec
  • A. Gentric



To evaluate the prescription of bisphosphonates in female nursing home residents aged 75 and older with a history of proximal femoral fracture.


Observational descriptive study, led in Brest, France, between June and August 2015.


12 nursing homes in Brest, France.


Female nursing home residents, aged 75 and older, with a history of proximal femoral fracture were included. Exclusion criteria were contraindications to bisphosphonate treatment and residents restricted to bed and chair.


The primary endpoint was the evaluation of prescription of bisphosphonates at the time of the study. The secondary endpoints were to evaluate vitamin D supplementation and factors associated with bisphosphonate prescription.


12 of the 116 included residents (10.3 %) received bisphosphonates. 66.4 % received vitamin D supplementation.


Despite successive French and international recommendations, there is still a very important underuse of treatment by bisphosphonates in old institutionalized female patients with a very high risk of fracture.

Key words

Osteoporosis proximal femoral fracture nursing homes bisphosphonates underuse 


  1. 1.
    Rosen CJ. The Epidemiology and Pathogenesis of Osteoporosis. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, et al., editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000 [cited 2015 May 17]. Available from: Google Scholar
  2. 2.
    Briot, K, Maravic, M, Roux, C. Changes in number and incidence of hip fractures over 12 years in France. Bone. 2015 Dec;81:131–7.CrossRefGoogle Scholar
  3. 3.
    Bliuc, D, Nguyen, ND, Milch, VE, Nguyen, TV, Eisman, JA, Center, JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009 Feb 4;301(5):513–21.CrossRefGoogle Scholar
  4. 4.
    Oleksik, A, Lips, P, Dawson, A, Minshall, ME, Shen, W, Cooper, C, et al. Healthrelated quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res Off J Am Soc Bone Miner Res. 2000 Jul;15(7):1384–92.CrossRefGoogle Scholar
  5. 5.
    Cauley, JA, Thompson, DE, Ensrud, KC, Scott, JC, Black, D. Risk of mortality following clinical fractures. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2000;11(7):556–61.CrossRefGoogle Scholar
  6. 6.
    Lindsay, R, Silverman, SL, Cooper, C, Hanley, DA, Barton, I, Broy, SB, et al. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001 Jan 17;285(3):320–3.CrossRefGoogle Scholar
  7. 7.
    Developing NICE guidelines: the manual | Guidance and guidelines | NICE [Internet]. [cited 2018 Jul 20]. Available from:
  8. 8.
    Briot, K, Roux, C, Thomas, T, Blain, H, Buchon, D, Chapurlat, R, et al. 2018 update of French recommendations on the management of postmenopausal osteoporosis. Jt Bone Spine Rev Rhum. 2018 Apr 11Google Scholar
  9. 9.
    Tuck, S, Little, EA, Aspray, TJ. Implications of guidelines for osteoporosis and its treatment. Age Ageing. 2018 May 1;47(3):334–9.CrossRefGoogle Scholar
  10. 10.
    Aguilar, EA, Barry, SD, Cefalu, CA, Abdo, A, Hudson, WP, Campbell, JS, et al. Osteoporosis Diagnosis and Management in Long-Term Care Facility. Am J Med Sci. 2015 Nov;350(5):357–63.CrossRefGoogle Scholar
  11. 11.
    Zarowitz, BJ, Cheng L-I, Allen, C, O’Shea, T, Stolshek, B. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis. J Am Med Dir Assoc. 2015 Apr;16(4):341–8.CrossRefGoogle Scholar
  12. 12.
    Sambrook, PN, Cameron, ID, Chen, JS, March, LM, Simpson, JM, Cumming, RG, et al. Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Osteoporos Int. 2011 Sep;22(9):2551–6.CrossRefGoogle Scholar
  13. 13.
    Bouvet, A, Sabatier, B, Savoldelli, V, Caruba, T, Pouchot, J. Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2014 Sep;20(6):347–8.Google Scholar
  14. 14.
    Parikh, S, Brookhart, MA, Stedman, M, Avorn, J, Mogun, H, Solomon, DH. Correlations of nursing home characteristics with prescription of osteoporosis medications. Bone. 2011 May 1;48(5):1164–8.CrossRefGoogle Scholar
  15. 15.
    Colón-Emeric, C, Lyles, K, Levine, D, House, P, Schenck, A, Gorospe, J, et al. Prevalence and Predictors of Osteoporosis Treatment in Nursing Home Residents with Known Osteoporosis or Recent Fracture. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2007 Apr;18(4):553–9.CrossRefGoogle Scholar
  16. 16.
    Cortet, B, Bénichou, O. Adhérence, observance, persistance, concordance: prenonsnous en charge correctement nos patientes ostéoporotiques? Rev Rhum. 2006 Oct;73(9):e1–9.CrossRefGoogle Scholar
  17. 17.
    Kamel, HK. Underutilization of calcium and vitamin D supplements in an academic long-term care facility. J Am Med Dir Assoc. 2004 Apr;5(2):98–100.CrossRefGoogle Scholar
  18. 18.
    Duque, G, Lord, SR, Mak, J, Ganda, K, Close, JJT, Ebeling, P, et al. Treatment of Osteoporosis in Australian Residential Aged Care Facilities: Update on Consensus Recommendations for Fracture Prevention. J Am Med Dir Assoc. 2016 Sep 1;17(9):852–9.CrossRefGoogle Scholar
  19. 19.
    Papaioannou, A, Santesso, N, Morin, SN, Feldman, S, Adachi, JD, Crilly, R, et al. Recommendations for preventing fracture in long-term care. CMAJ Can Med Assoc J J Assoc Medicale Can. 2015 Oct 20;187(15):1135–44, E450–61.CrossRefGoogle Scholar

Copyright information

© Serdi and Springer-Verlag International SAS, part of Springer Nature 2019

Authors and Affiliations

  1. 1.CHRU de BrestBrestFrance

Personalised recommendations